Last10K.com

Sigma Aldrich Corp (SIAL) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2015

Sigma Aldrich Corp

CIK: 90185 Ticker: SIAL


        



3050 Spruce Street, St. Louis, MO 63103 USA
Tel: (800) 521-8956 (314) 771-5765 Fax: (800) 325-5052 (314) 771-5757


FOR IMMEDIATE RELEASE - St. Louis, MO, May 7, 2015

SIGMA-ALDRICH (NASDAQ - SIAL) REPORTS Q1 2015 SALES OF $676 MILLION AND ADJUSTED DILUTED EPS OF $1.06. DECLARES $0.23 QUARTERLY DIVIDEND.

HIGHLIGHTS:
 
Q1 2015 Results (all percentage changes are against comparable periods in 2014)
Reported sales were $676 million compared to $689 million in the first quarter of 2014. Sales grew organically by 5%. Recent acquisitions increased sales by 1%. Changes in foreign currency exchange rates decreased sales by 8%.
By business unit, organic sales growth was 3% in Research, 6% in Applied and 10% in SAFC Commercial.
Reported diluted EPS was $1.04 compared to $1.05 in the first quarter of 2014. Adjusted diluted EPS (excluding $3 million of pre-tax merger-related costs) was $1.06, the same as in the first quarter of 2014. Changes in foreign currency exchange rates reduced first quarter 2015 adjusted EPS by $0.13. Excluding this impact, adjusted diluted EPS would have been $1.19, an increase of 12% from the same period last year.

Quarterly Dividend
On May 5, the Company’s Board of Directors conditionally approved a quarterly cash dividend of $0.23 per share to shareholders of record on June 1, 2015. Payment of that dividend will be made on June 15, 2015 so long as the transaction by which Merck KGaA is to acquire all of the outstanding shares of the Company has not closed prior to that date.
 

CEO’s STATEMENT:
 
Commenting on performance in the first quarter of 2015, President and CEO Rakesh Sachdev said, “I am pleased to report that our teams delivered solid organic sales growth with contribution from all business units and major geographies. Despite a significant negative sales impact from unfavorable year-over-year changes in foreign currency exchange rates, the Company expanded adjusted operating margin and grew adjusted operating income.

Our Research business unit had growth contribution from all segments and geographies, continuing a trend that began in the second half of last year. Our Applied business unit was led by double-digit growth in the Diagnostics and Testing segment. Our SAFC Commercial business unit was led by the seventh consecutive quarter of double-digit organic sales growth in the Life Sciences Services segment and solid growth in the Life

1

The following information was filed by Sigma Aldrich Corp (SIAL) on Thursday, May 7, 2015 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Sigma Aldrich Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sigma Aldrich Corp.

Continue

Assess how Sigma Aldrich Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sigma Aldrich Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Income
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (changes In Accumulated Other Comprehensive Income By Component) (details)
Accumulated Other Comprehensive Income (narrative) (details)
Accumulated Other Comprehensive Income (tables)
Basis Of Presentation
Company Operations By Business Unit
Company Operations By Business Unit (geographic Financial Information - Long-lived Assets) (details)
Company Operations By Business Unit (geographic Financial Information - Net Sales To Unaffiliated Customers) (details)
Company Operations By Business Unit (net Sales For The Company's Business Units) (details)
Company Operations By Business Unit (tables)
Contingent Liabilities And Commitments
Contingent Liabilities And Commitments (details)
Debt
Debt (narrative) (details)
Debt (notes Payable And Long-term Debt - Additional Information) (details)
Debt (schedule Of Notes Payable And Long-term Debt) (details)
Debt (tables)
Earnings Per Share
Earnings Per Share (shares Used In Calculation Of Earnings Per Share) (details)
Earnings Per Share (tables)
Financial Derivatives And Risk Management
Financial Derivatives And Risk Management (fair Value Of Derivatives) - Balance Sheet (details)
Financial Derivatives And Risk Management (general Cash Flow Hedge Information) (details)
Financial Derivatives And Risk Management (schedule Of Gain Loss) - Income Statement (details)
Financial Derivatives And Risk Management (tables)
Intangible Assets
Intangible Assets (amortizable And Unamortizable Intangible Assets) (details)
Intangible Assets (change In Net Goodwill) (details)
Intangible Assets (narrative) (details)
Intangible Assets (tables)
Inventories
Inventories (principal Categories Of Inventories) (details)
Inventories (tables)
Other Assets And Liabilities
Other Assets And Liabilities (other Assets) (details)
Other Assets And Liabilities (other Current Assets) (details)
Other Assets And Liabilities (other Current Liabilities) (details)
Other Assets And Liabilities (other Liabilities) (details)
Other Assets And Liabilities (tables)
Other Charges
Other Charges (details)
Other Charges (tables)
Pension And Post-retirement Benefits
Pension And Post-retirement Benefits (components Of The Net Periodic Benefit Costs) (details)
Pension And Post-retirement Benefits (narrative) (details)
Pension And Post-retirement Benefits (pension And Post-retirement Benefits And Liabilities) (details)
Pension And Post-retirement Benefits (tables)
Proposed Merger With Merck Kgaa
Proposed Merger With Merck Kgaa (details)
Share Repurchases
Share Repurchases (details)

Material Contracts, Statements, Certifications & more

Sigma Aldrich Corp provided additional information to their SEC Filing as exhibits

Ticker: SIAL
CIK: 90185
Form Type: 10-Q Quarterly Report
Accession Number: 0000090185-15-000070
Submitted to the SEC: Thu May 07 2015 9:48:19 AM EST
Accepted by the SEC: Thu May 07 2015
Period: Tuesday, March 31, 2015
Industry: Wholesale Chemicals And Allied Products

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/sial/0000090185-15-000070.htm